“(Ending the waiver) stops setting aside buprenorphine as another medicine that needs some kind of special understanding in order to utilize it clinically,” said Josh Blum, a Denver Health physician and past president of the Colorado chapter of the American Society of Addiction Medicine [and associate professor of medicine at CU School of Medicine].
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045